Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR4 | P22455 | 3/20 | 0.50 |
| ▸ | PIM1 | P11309 | 2/20 | 0.33 |
| ▸ | TTK | P33981 | 2/20 | 0.33 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1522002 | 0.83 | FGFR4 (0.49) | FGFR4PIM1TTKPIM2MEN1 | |
| SCHEMBL6619641 | 0.78 | FGFR4 (0.45) | FGFR4PIM1TTKPIM2MEN1 | |
| SCHEMBL30955695 | 0.78 | FGFR4 (0.45) | FGFR4PIM1TTKPIM2 | |
| SCHEMBL1521639 | 0.78 | FGFR4 (0.50) | FGFR4PIM1TTKPIM2 | |
| SCHEMBL24170655 | 0.78 | FGFR4 (0.47) | FGFR4PIM1TTKPIM2MEN1 | |
| SCHEMBL30955632 | 0.77 | FGFR4 (0.41) | FGFR4RXFP1 | |
| SCHEMBL30955707 | 0.77 | FGFR4 (0.44) | FGFR4PIM1TTKPIM2 | |
| SCHEMBL1521518 | 0.74 | FGFR4 (0.42) | FGFR4PIM1TTKPIM2 | |
| SCHEMBL30955648 | 0.74 | MAPK8 (0.37) | FGFR4 | |
| SCHEMBL1521955 | 0.72 | FGFR4 (0.46) | FGFR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024131893-A1 | IRE1α SMALL MOLECULE INHIBITORS | SHANGHAI YI ZHONG XING BIOTECHNOLOGY CO., LTD. (CN) | 2024-06-27 | — | — | WO | disclosed |